VIM and breast cancer: In BC cells, miR-138 targeted regulation of SEMA4C can promote the expression of N-cad, inhibit the expression of E-cad, Vim, and SEMA4C, and reverse the EMT of BC cells, thereby inhibiting the viability and invasion ability of BC cells.